IPIC Message Board - Msg: 2230793

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Dec 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: paul001 who wrote (703)	9/19/1997 2:46:00 PM
From: Todd D. Wiener	of 1359

Yes, absolutely. First of all, since when has a stock's market cap been dependent upon sales & earnings? IPIC has lots of speculative value (not an oxymoron), because its phase III pipeline is very good. Unlike some biotechs, which have one or two products (or more) either in early clinical trials or at different levels of development, IPIC has 3 drugs which should receive marketing approval within the next 2-3 years. That would quickly transform IPIC into a legitimate drug company, worthy of a market cap far above today's value. Todd

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next